Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-10

Clinical Trial Update: A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance for the Detection of Calcified Coronary Arteries

View source ↗

Summary

Ongoing clinical trial evaluating ferumoxytol-enhanced cardiac MRI for detecting calcified coronary arteries; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FERUMOXYTOL (ferumoxytol)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Coronary Artery Calcification | Status: RECRUITING